Stockreport

IPA to Report Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2025 on December 10, 2024 [Yahoo! Finance]

ImmunoPrecise Antibodies Ltd.  (IPA) 
PDF ANTIBODIES LTD.) (the "Company" or "IPA") (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, today announced that it will host a conference call [Read more]